Cargando…

Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac

Present technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, P., Helmreich, B., Škrbić, B., Carballa, M., Papa, M., Pastore, C., Emre, Z., Oehmen, A., Langenhoff, A., Molinos, M., Dvarioniene, J., Huber, C., Tsagarakis, K. P., Martinez-Lopez, E., Pagano, S. Meric, Vogelsang, C., Mascolo, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912981/
https://www.ncbi.nlm.nih.gov/pubmed/27023823
http://dx.doi.org/10.1007/s11356-016-6503-x
_version_ 1782438343339933696
author Schröder, P.
Helmreich, B.
Škrbić, B.
Carballa, M.
Papa, M.
Pastore, C.
Emre, Z.
Oehmen, A.
Langenhoff, A.
Molinos, M.
Dvarioniene, J.
Huber, C.
Tsagarakis, K. P.
Martinez-Lopez, E.
Pagano, S. Meric
Vogelsang, C.
Mascolo, G.
author_facet Schröder, P.
Helmreich, B.
Škrbić, B.
Carballa, M.
Papa, M.
Pastore, C.
Emre, Z.
Oehmen, A.
Langenhoff, A.
Molinos, M.
Dvarioniene, J.
Huber, C.
Tsagarakis, K. P.
Martinez-Lopez, E.
Pagano, S. Meric
Vogelsang, C.
Mascolo, G.
author_sort Schröder, P.
collection PubMed
description Present technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this problem of organic pollutants was taken into account by the Directive 2013/39/EU that introduced (i) the quality evaluation of aquatic compartments, (ii) the polluter pays principle, (iii) the need for innovative and affordable wastewater treatment technologies, and (iv) the identification of pollution causes including a list of principal compounds to be monitored. In addition, a watch list of 10 other substances was recently defined by Decision 2015/495 on March 20, 2015. This list contains, among several recalcitrant chemicals, the painkiller diclofenac and the hormones 17β-estradiol and 17α-ethinylestradiol. Although some modern approaches for their removal exist, such as advanced oxidation processes (AOPs), retrofitting most wastewater treatment plants with AOPs will not be acceptable as consistent investment at reasonable operational cost. Additionally, by-product and transformation product formation has to be considered. The same is true for membrane-based technologies (nanofiltration, reversed osmosis) despite of the incredible progress that has been made during recent years, because these systems lead to higher operation costs (mainly due to higher energy consumption) so that the majority of communities will not easily accept them. Advanced technologies in wastewater treatment like membrane bioreactors (MBR) that integrate biological degradation of organic matter with membrane filtration have proven a more complete elimination of emerging pollutants in a rather cost- and labor-intensive technology. Still, most of the presently applied methods are incapable of removing critical compounds completely. In this opinion paper, the state of the art of European WWTPs is reflected, and capacities of single methods are described. Furthermore, the need for analytical standards, risk assessment, and economic planning is stressed. The survey results in the conclusion that combinations of different conventional and advanced technologies including biological and plant-based strategies seem to be most promising to solve the burning problem of polluting our environment with hazardous emerging xenobiotics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11356-016-6503-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4912981
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49129812016-07-06 Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac Schröder, P. Helmreich, B. Škrbić, B. Carballa, M. Papa, M. Pastore, C. Emre, Z. Oehmen, A. Langenhoff, A. Molinos, M. Dvarioniene, J. Huber, C. Tsagarakis, K. P. Martinez-Lopez, E. Pagano, S. Meric Vogelsang, C. Mascolo, G. Environ Sci Pollut Res Int Review Article Present technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this problem of organic pollutants was taken into account by the Directive 2013/39/EU that introduced (i) the quality evaluation of aquatic compartments, (ii) the polluter pays principle, (iii) the need for innovative and affordable wastewater treatment technologies, and (iv) the identification of pollution causes including a list of principal compounds to be monitored. In addition, a watch list of 10 other substances was recently defined by Decision 2015/495 on March 20, 2015. This list contains, among several recalcitrant chemicals, the painkiller diclofenac and the hormones 17β-estradiol and 17α-ethinylestradiol. Although some modern approaches for their removal exist, such as advanced oxidation processes (AOPs), retrofitting most wastewater treatment plants with AOPs will not be acceptable as consistent investment at reasonable operational cost. Additionally, by-product and transformation product formation has to be considered. The same is true for membrane-based technologies (nanofiltration, reversed osmosis) despite of the incredible progress that has been made during recent years, because these systems lead to higher operation costs (mainly due to higher energy consumption) so that the majority of communities will not easily accept them. Advanced technologies in wastewater treatment like membrane bioreactors (MBR) that integrate biological degradation of organic matter with membrane filtration have proven a more complete elimination of emerging pollutants in a rather cost- and labor-intensive technology. Still, most of the presently applied methods are incapable of removing critical compounds completely. In this opinion paper, the state of the art of European WWTPs is reflected, and capacities of single methods are described. Furthermore, the need for analytical standards, risk assessment, and economic planning is stressed. The survey results in the conclusion that combinations of different conventional and advanced technologies including biological and plant-based strategies seem to be most promising to solve the burning problem of polluting our environment with hazardous emerging xenobiotics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11356-016-6503-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-03-29 2016 /pmc/articles/PMC4912981/ /pubmed/27023823 http://dx.doi.org/10.1007/s11356-016-6503-x Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Schröder, P.
Helmreich, B.
Škrbić, B.
Carballa, M.
Papa, M.
Pastore, C.
Emre, Z.
Oehmen, A.
Langenhoff, A.
Molinos, M.
Dvarioniene, J.
Huber, C.
Tsagarakis, K. P.
Martinez-Lopez, E.
Pagano, S. Meric
Vogelsang, C.
Mascolo, G.
Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
title Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
title_full Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
title_fullStr Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
title_full_unstemmed Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
title_short Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
title_sort status of hormones and painkillers in wastewater effluents across several european states—considerations for the eu watch list concerning estradiols and diclofenac
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912981/
https://www.ncbi.nlm.nih.gov/pubmed/27023823
http://dx.doi.org/10.1007/s11356-016-6503-x
work_keys_str_mv AT schroderp statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT helmreichb statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT skrbicb statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT carballam statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT papam statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT pastorec statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT emrez statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT oehmena statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT langenhoffa statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT molinosm statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT dvarionienej statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT huberc statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT tsagarakiskp statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT martinezlopeze statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT paganosmeric statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT vogelsangc statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac
AT mascolog statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac